We are live on ! Find out more
FRLN

Freeline Therapeutics Holdings plc American Depositary Shares

Delisted

FRLN was delisted on the 16th of February, 2024.

12 hedge funds and large institutions have $9.87M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

94% more capital invested

Capital invested by funds: $5.09M → $9.87M (+$4.78M)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

9% more funds holding

Funds holding: 1112 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
5
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

FRLN Hedge Fund Activity: Q3 2023 in Review

12 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q3 2023, worth a combined $9.87M — up 94% from $5.09M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new FRLN positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.47M. The largest seller was Tang Capital Management, exiting entirely with an estimated $258K sold.

  • 12 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q3 2023, up from 11 in Q2 2023.
  • Funds reported $9.87M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q3 2023, up 94% quarter-over-quarter.
  • 3 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q3 2023 and 2 closed out, a net change of +1 holder.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q3 2023 was Millennium Management, an estimated $1.47M added.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q3 2023 was Tang Capital Management, an estimated $258K sold.

Based on aggregated 13F filings for Q3 2023.